Monday: My day starts on the tube with a check of my emails as I go to work. There is a lot going on at the charity so I need to start work as early as I can. When I arrive, I have a meeting with the donor recruitment team to discuss our patient appeals. They've generated a great response: thousands of people have joined our blood stem cell registry as a result. In the afternoon, I head to Westminster for an event in parliament about blood stem cell registration in the UK.
Tuesday: I have a meeting with our medical team. We have had several people donate blood stem cells in the past few weeks. One of the donors was recruited at an event that we ran in a mosque last year. We've been trying to reach out to minority ethnic communities because blood cancer patients from non-white English backgrounds are less likely to find matches.
Wednesday: We are about to launch a new-look website and I spend most of the morning reviewing progress with the web team. The site looks great and, thankfully, there haven't been any problems with it. At lunchtime, I run out to the local bookshop to buy a book for my son - I end up treating myself to a couple of books too. In the afternoon, I have a conference call with the US public relations team of one of our corporate supporters.
Thursday: Lots of meetings today, but I manage a treat in between them. It's the marketing manager's birthday and one of the team has baked an amazing chocolate cake. It would have been rude to say no to a slice.
Friday: The charity recently ran a recruitment drive initiated by the staff of the Department for Business, Innovation and Skills, so this morning I have a meeting with the donor recruitment manager about this.
I have a conference call with members of Delete Blood Cancer US, our sister charity with which we are working on a number of appeals. We agree on a campaign for a sick patient who lives in Italy but has family in the UK. I'm flagging by the afternoon, so I have a cup of coffee that is so strong it could fuel a rocket.
Delete Blood Cancer UK aims to increase the number of stem cell donors